These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4039625)

  • 1. Doxorubicin plus cisplatin in the treatment of apudomas.
    Sridhar KS; Holland JF; Brown JC; Cohen JM; Ohnuma T
    Cancer; 1985 Jun; 55(11):2634-7. PubMed ID: 4039625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
    Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
    Içli F; Karaoguz H; Akbulut H; Dinçol D; Demirkazik A; Cay F
    J Surg Oncol; 1997 Apr; 64(4):318-23. PubMed ID: 9142190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
    Thigpen JT; Brady MF; Homesley HD; Malfetano J; DuBeshter B; Burger RA; Liao S
    J Clin Oncol; 2004 Oct; 22(19):3902-8. PubMed ID: 15459211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
    Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
    Am J Clin Oncol; 1988 Aug; 11(4):490-5. PubMed ID: 2841843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent and metastatic endometrial carcinoma with cisplatin and doxorubicin.
    Deppe G; Malviya VK; Malone JM; Christensen CW; Saunders D
    Eur J Gynaecol Oncol; 1994; 15(4):263-6. PubMed ID: 7957332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
    Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
    Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 5-fluorouracil, pirarubicin and low-dose consecutive administration of cisplatin for advanced and recurrent gastric cancer.
    Kikuyama S; Inada T; Miyakita M; Ogata Y
    Jpn J Clin Oncol; 1998 May; 28(5):314-7. PubMed ID: 9703858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
    Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
    Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
    Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
    J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases.
    Vogl S; Ohnums T; Perloff M; Holland JF
    Cancer; 1976 Jul; 38(1):21-6. PubMed ID: 985619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study.
    Lancet; 1998 Nov; 352(9140):1571-6. PubMed ID: 9843101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.
    Khandekar JD; Elson PJ; DeWys WD; Slayton RE; Harris DT
    J Clin Oncol; 1985 Apr; 3(4):539-45. PubMed ID: 3884746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.